Vitiligo Repigmentation After SARS-CoV-2 Vaccine

Vitiligo Repigmentation After SARS-CoV-2 Vaccine

Authors

  • Roberto Bustos-Macaya Dermatology Unit, Barros Luco Hospital, Santiago de Chile, Chile
  • Francisco González-Coloma Department of Dermatology, Faculty of Medicine, University de Chile, Santiago de Chile, Chile
  • Juan Pablo Morales Etcheberry Department of Dermatology, Faculty of Medicine, University de Chile, Santiago de Chile, Chile
  • Laura Segovia Pathology Anatomy Unit, Barros Luco Hospital, Santiago de Chile, Chile

References

References

Seirafianpour F, Pourriyahi H, Gholizadeh Mesgarha M, Pour Mohammad A, Shaka Z, Goodarzi A. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders. Dermatol Ther. 2022;35(6):e15461. doi:10.1111/dth.15461

McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46-55. doi:10.1016/j.jaad.2021.03.092

Downloads

Published

2023-10-31

Issue

2023 Vol 13, No 4 | October

Section

Image Letter

License

Copyright (c) 2023 Juan Pablo Morales Etcheberry, Roberto Bustos-Macaya, Francisco González-Coloma, Laura Segovia

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.

How to Cite

1.
Bustos-Macaya R, González-Coloma F, Morales Etcheberry JP, Segovia L. Vitiligo Repigmentation After SARS-CoV-2 Vaccine. Dermatol Pract Concept. 2023;13(4):e2023236. doi:10.5826/dpc.1304a236

Share

Crossref
Scopus
Google Scholar
Europe PMC